We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+15.9%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$581M
AUM Growth
+$48.1M
Cap. Flow
-$18.4M
Cap. Flow %
-3.16%
Top 10 Hldgs %
44.77%
Holding
84
New
1
Increased
27
Reduced
9
Closed
15

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.29M
2
MSFT icon
Microsoft
MSFT
+$4.86M
3
SYY icon
Sysco
SYY
+$4.48M
4
SBUX icon
Starbucks
SBUX
+$3.11M
5
ALGN icon
Align Technology
ALGN
+$2.35M

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 18.75%
3 Financials 15.82%
4 Consumer Discretionary 14.41%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.98T
$40.9M 7.03%
97,103
+12,016
+14% +$4.86M
NVDA icon
2
NVIDIA
NVDA
$5.02T
$35.2M 6.06%
389,760
-28,320
-7% -$2.05M
AAPL icon
3
Apple
AAPL
$4.89T
$29.1M 5.01%
169,786
+8,728
+5% +$1.59M
META icon
4
Meta Platforms (Facebook)
META
$1.69T
$28.7M 4.93%
59,054
-12,994
-18% -$5.8M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.33T
$25.4M 4.37%
168,454
+36,998
+28% +$5.29M
AMZN icon
6
Amazon
AMZN
$2.69T
$24.4M 4.19%
135,142
-14,998
-10% -$2.5M
ABBV icon
7
AbbVie
ABBV
$449B
$21.2M 3.64%
116,181
+6,534
+6% +$1.13M
TGT icon
8
Target
TGT
$63.7B
$19.6M 3.37%
110,490
+8,562
+8% +$1.3M
ISRG icon
9
Intuitive Surgical
ISRG
$142B
$18.9M 3.25%
47,397
-4,952
-9% -$1.87M
GS icon
10
Goldman Sachs
GS
$323B
$17M 2.92%
40,662
+2,763
+7% +$1.07M
MA icon
11
Mastercard
MA
$487B
$16.7M 2.88%
34,776
+2,705
+8% +$1.24M
TJX icon
12
TJX Companies
TJX
$171B
$16.7M 2.88%
165,036
+11,443
+7% +$1.11M
ADI icon
13
Analog Devices
ADI
$185B
$15.3M 2.63%
77,434
+5,825
+8% +$1.12M
SYY icon
14
Sysco
SYY
$39.3B
$15.3M 2.63%
188,517
+56,816
+43% +$4.48M
EMR icon
15
Emerson Electric
EMR
$77.9B
$15.1M 2.6%
133,516
+11,497
+9% +$1.18M
CVS icon
16
CVS Health
CVS
$136B
$14.9M 2.56%
186,404
+13,447
+8% +$1.03M
WFC icon
17
Wells Fargo
WFC
$267B
$14.5M 2.5%
251,006
+19,656
+8% +$1.03M
SBUX icon
18
Starbucks
SBUX
$124B
$14.5M 2.49%
158,350
+33,451
+27% +$3.11M
ULTA icon
19
Ulta Beauty
ULTA
$20.6B
$13.1M 2.25%
24,997
+2,093
+9% +$1.08M
TMO icon
20
Thermo Fisher Scientific
TMO
$202B
$12.9M 2.22%
22,223
+1,784
+9% +$1M
EW icon
21
Edwards Lifesciences
EW
$50.6B
$12.8M 2.21%
134,470
+11,149
+9% +$937K
CB icon
22
Chubb
CB
$133B
$12.7M 2.18%
48,824
+3,780
+8% +$929K
V icon
23
Visa
V
$694B
$12.2M 2.1%
43,653
+3,041
+7% +$840K
MRVL icon
24
Marvell Technology
MRVL
$169B
$12M 2.06%
168,712
+14,062
+9% +$963K
CSX icon
25
CSX Corp
CSX
$94.6B
$11.2M 1.92%
301,330
+20,189
+7% +$737K

Similar funds

Waycross Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Waycross Partners held 84 positions worth $581M, up 9% from $533M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Waycross Partners withdrew a net $18.4M in Q1 2024, closing 15 positions and reducing 9 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Waycross Partners opened a new position in Align Technology worth $2.62M.

  • Waycross Partners's largest Q1 2024 buy was Align Technology: 8,000 shares worth $2.62M.
  • Waycross Partners added most to Alphabet (Google) Class A in Q1 2024, an estimated $5.29M increase.
  • Waycross Partners's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $5.8M.
  • Waycross Partners fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $21.4M.
  • Waycross Partners's ten largest holdings make up 45% of its $581M portfolio in Q1 2024.
  • Waycross Partners opened 1 new position and closed 15 in Q1 2024.
  • Waycross Partners's portfolio value rose 9% quarter-over-quarter to $581M.

Based on Waycross Partners's 13F filing for Q1 2024, filed 2 May 2024.